Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Healthy Subject Population”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00903448
What this trial is testing

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Who this might be right for
Healthy
Procter and Gamble 40
Early research (Phase 1)Study completedNCT02871570
What this trial is testing

Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Who this might be right for
Moderate Hepatic ImpairmentNormal Hepatic Function
GlycoMimetics Incorporated 16
Early research (Phase 1)Study completedNCT01844739
What this trial is testing

Study Evaluating Safety and Tolerability of NVN1000 Gel

Who this might be right for
Acne Vulgaris
Novan, Inc. 30
Early research (Phase 1)Study completedNCT02372084
What this trial is testing

Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT01569828
What this trial is testing

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Who this might be right for
PharmacokineticsRenal ImpairedHealthy Volunteer
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT01429337
What this trial is testing

PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 43
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)UnknownNCT05451199
What this trial is testing

A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis

Who this might be right for
Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 154
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Early research (Phase 1)Study completedNCT03207425
What this trial is testing

EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Who this might be right for
NASH
Enanta Pharmaceuticals, Inc 29
Early research (Phase 1)Study completedNCT02923583
What this trial is testing

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Who this might be right for
Healthy Volunteers
Momenta Pharmaceuticals, Inc. 243
Testing effectiveness (Phase 2)Study completedNCT01621633
What this trial is testing

LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Looking for participantsNCT07694869
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function

Who this might be right for
Healthy ParticipantsParticipants With Moderate Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 16
Early research (Phase 1)Study completedNCT03714022
What this trial is testing

Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 140
Early research (Phase 1)Study completedNCT01583530
What this trial is testing

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Who this might be right for
Healthy
Human Genome Sciences Inc. 118
Early research (Phase 1)Study completedNCT02474537
What this trial is testing

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 31
Not applicableStudy completedNCT03327870
What this trial is testing

Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population

Who this might be right for
Sjogren's SyndromeOral Health
National Institute of Dental and Craniofacial Research (NIDCR) 166
Early research (Phase 1)Study completedNCT05323708
What this trial is testing

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS

Who this might be right for
Healthy Volunteers
Biocon Biologics UK Ltd 190
Early research (Phase 1)Looking for participantsNCT07800104
What this trial is testing

Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
QuantX Biosciences, Inc. 84
Next Page